Increasing pyomyositis presentations among children in Queensland, Australia

Pediatric Infectious Disease Journal

Volumn 34, Issue 1, 2015, Pages 1-4

  Moriarty, Paul ^a   Leung, Clare ^a   Walsh, Mark ^a   Nourse, Clare ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b LADY CILENTO CHILDREN S HOSPITAL   (Australia)

Author keywords

Musculoskeletal infection; Pediatric infection; Pyomyositis; Staphylococcus aureus; Tropical pyomyositis

Indexed keywords

ANTIINFECTIVE AGENT; C REACTIVE PROTEIN; CLINDAMYCIN; FLUCLOXACILLIN;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; AUSTRALIA; BACTEREMIA; BLOOD CULTURE; CHILD; CHRONIC DISEASE; CHRONIC OSTEOMYELITIS; CLINICAL FEATURE; COHORT ANALYSIS; COMMUNITY ACQUIRED INFECTION; DIAGNOSTIC TEST; EMERGENCY WARD; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MUSCLE; MUSCLE WEAKNESS; NEUROLOGIC DISEASE; NEWBORN; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; PYOMYOSITIS; STREPTOCOCCUS GROUP A; TREATMENT OUTCOME; VERTEBRO PELVIC MUSCLE; BACTERIUM; CLASSIFICATION; INCIDENCE; ISOLATION AND PURIFICATION; PATHOLOGY; PRESCHOOL CHILD; PROCEDURES; QUEENSLAND; RETROSPECTIVE STUDY;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTERIA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; PYOMYOSITIS; QUEENSLAND; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84926154010     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000470     Document Type: Article

References (27)

1. Gubbay AJ, Isaacs D. Pyomyositis in children. Pediatr Infect Dis J. 2000;19:1009-1012; quiz 1013.
2. Unnikrishnan PN, Perry DC, George H, et al. Tropical primary pyomyositis in children of the UK: an emerging medical challenge. Int Orthop. 2010;34:109-113.
3. Bertrand SL, Lincoln ED, Prohaska MG. Primary pyomyositis of the pelvis in children: a retrospective review of 8 cases. Orthopedics. 2011;34:e832-e840.
4. Pannaraj PS, Hulten KG, Gonzalez BE, et al. Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2006;43:953-960.
5. Bonafede P, Butler J, Kimbrough R, et al. Temperate zone pyomyositis. West J Med. 1992;156:419-423.
6. Echeverria P, Vaughn MC. "Tropical pyomyositis." A diagnostic problem in temperate climates. Am J Dis Child. 1975;129:856-857.
7. Spiegel DA, Meyer JS, Dormans JP, et al. Pyomyositis in children and adolescents: report of 12 cases and review of the literature. J Pediatr Orthop. 1999;19:143-150.
8. Nimmo GR, Schooneveldt JM, Sutherland JL, et al. Epidemiology of non-multiresistant methicillin-resistant Staphylococcus aureus infection in Queensland, Australia: associations with indigenous populations and Panton-Valentine leukocidin. Eur J Clin Microbiol Infect Dis. 2010;29:1253-1259.
9. Nimmo GR, Bergh H, Nakos J, et al. Replacement of healthcare-associated MRSA by community-associated MRSA in Queensland: confirmation by genotyping. J Infect. 2013;67:439-447.
10. Nimmo GR, Schooneveldt JM, Sutherland JL, et al. Epidemiology of nonmultiresistant methicillin-resistant Staphylococcus aureus infection in Queensland, Australia: associations with indigenous populations and Panton-Valentine leukocidin. Eur J Clin Microbiol Infect Dis. 2010;29:1253-1259.
11. Britton PN, Andresen DN. Paediatric community-associated Staphylococcus aureus: a retrospective cohort study. J Paediatr Child Health. 2013;49:754-759.
12. Vander Have KL, Karmazyn B, Verma M, et al. Community-associated methicillin-resistant Staphylococcus aureus in acute musculoskeletal infection in children: a game changer. J Pediatr Orthop. 2009;29:927-931.
13. Nimmo GR, Fong J, Paterson DL, et al. Changing epidemiology of meticillinresistant S. aureus in Queensland, Australia, 2000-2006: use of passive surveillance of susceptibility phenotypes. J Hosp Infect. 2008;70:305-313.
14. Block AA, Marshall C, Ratcliffe A, et al. Staphylococcal pyomyositis in a temperate region: epidemiology and modern management. Med J Aust. 2008;189:323-325.
15. Cherry J, Harrison G, Kaplan S, et al. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. 7th ed. James D. Cherry, ed. Philadelphia: Saunders Elsevier; 2014: Chapter 57.
16. Vaska VL, Nimmo GR, Jones M, et al. Increases in Australian cutaneous abscess hospitalisations: 1999-2008. Eur J Clin Microbiol Infect Dis. 2012;31:93-96.
17. Tong SY, Chen LF, Fowler VG Jr. Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance? Semin Immunopathol. 2012;34:185-200.
18. Shallcross LJ, Fragaszy E, Johnson AM, et al. The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13:43-54.
19. Ritz N, Curtis N. The role of Panton-Valentine leukocidin in Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J. 2012;31:514-518.
20. Muttaiyah S, Coombs G, Pandey S, et al. Incidence, risk factors, and outcomes of Panton-Valentine leukocidin-positive methicillin-susceptible Staphylococcus aureus infections in Auckland, New Zealand. J Clin Microbiol. 2010;48:3470-3474.
21. Breurec S, Fall C, Pouillot R, et al.; Working Group on Staphylococcus aureus Infections. Epidemiology of methicillin-susceptible Staphylococcus aureus lineages in five major African towns: high prevalence of Panton-Valentine leukocidin genes. Clin Microbiol Infect. 2011;17:633-639.
22. Munckhof WJ, Nimmo GR, Carney J, et al. Methicillin-susceptible, nonmultiresistant methicillin-resistant and multiresistant methicillin-resistant Staphylococcus aureus infections: a clinical, epidemiological and microbiological comparative study. Eur J Clin Microbiol Infect Dis. 2008;27:355-364.
23. Meehan J, Grose C, Soper RT, et al. Pyomyositis in an adolescent female athlete. J Pediatr Surg. 1995;30:127-128.
24. Gafur OA, Copley LA, Hollmig ST, et al. The impact of the current epidemiology of pediatric musculoskeletal infection on evaluation and treatment guidelines. J Pediatr Orthop. 2008;28:777-785.
25. Peltola H, Pääkkönen M, Kallio P, et al.; OM-SA Study Group. Clindamycin vs. first-generation cephalosporins for acute osteoarticular infections of childhood-a prospective quasi-randomized controlled trial. Clin Microbiol Infect. 2012;18:582-589.
26. Pääkkönen M, Kallio MJ, Kallio PE, et al. Sensitivity of erythrocyte sedimentation rate and C-reactive protein in childhood bone and joint infections. Clin Orthop Relat Res. 2010;468:861-866.
27. Pääkkönen M, Peltola H. Bone and joint infections. Pediatr Clin North Am. 2013;60:425-436.